$ETNB

89bio Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$3.12 ▲3.311%

Delayed Price

VOLUME

60,812

DAY RANGE

- 3.12

52 WEEK

2 - 21.47

Join Discuss about ETNB with like-minded investors

profile
@achatzi #ivtrades
recently

GM all $ETNB , nice bounce. @Marcosx did you in ?

142 Replies 15 👍 8 🔥

profile
@Marcosx #ivtrades
recently

achatzi ETNB trying again that is one low volume sucker

145 Replies 13 👍 13 🔥

profile
@achatzi #ivtrades
recently

$ETNB : ready for a Bullish reversal at 13.15 - 13.25 $

67 Replies 9 👍 12 🔥

profile
@dros #droscrew
recently

+Initiations 12/20: $ASML $AYLA $BCDA $BEAT $CCB $CMPX $CNNE $CRWD $CTOS $EDSA $ETNB $FNV $NOK $PRPH $SOFI $STM . -Initiations 12/20:

149 Replies 13 👍 14 🔥

Key Metrics

Market Cap

61.46 M

Beta

1.19

Avg. Volume

558.87 K

Shares Outstanding

20.35 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel.

Website:

HQ: ,

Related News